Serological assessment of SARS-CoV-2 specific responses are an essential tool for determining the prevalence of past SARS-CoV-2 infections in the population especially when testing occurs after symptoms have developed and limited contact tracing is in place. The goal of our study was to test a new 10-plex electro-chemiluminescence-based assay to measure IgM and IgG responses to the spike proteins from multiple human coronaviruses including SARS-CoV-2, assess the epitope specificity of the SARS-CoV-2 antibody response against full-length spike protein, receptor-binding domain and N-terminal domain of the spike protein, and the nucleocapsid protein. We carried out the assay on samples collected from three sample groups: subjects diagnosed with COVID-19 from the U.S. Army hospital at Camp Humphreys in Pyeongtaek, South Korea; healthcare administrators from the same hospital but with no reported diagnosis of COVID-19; and pre-pandemic samples. We found that the new CoV-specific multiplex assay was highly sensitive allowing plasma samples to be diluted 1:30,000 with a robust signal. The reactivity of IgG responses to SARS-CoV-2 nucleocapsid protein and IgM responses to SARS-CoV-2 spike protein could distinguish COVID-19 samples from non-COVID-19 and pre-pandemic samples. The data from the three sample groups also revealed a unique pattern of cross-reactivity between SARS-CoV-2 and SARS-CoV-1, MERS-CoV, and seasonal coronaviruses HKU1 and OC43. Our findings show that the CoV-2 IgM response is highly specific while the CoV-2 IgG response is more cross-reactive across a range of human CoVs and also showed that IgM and IgG responses show distinct patterns of epitope specificity. In summary, this multiplex assay was able to distinguish samples by COVID-19 status and characterize distinct trends in terms of cross-reactivity and fine-specificity in antibody responses, underscoring its potential value in diagnostic or serosurveillance efforts.
【초록키워드】 COVID-19, SARS-CoV-2, antibody, SARS-COV-2 infection, hospital, Antibody Response, diagnostic, Diagnosis, Contact tracing, Symptom, MERS, SARS-CoV-1, MERS-CoV, Spike protein, nucleocapsid protein, cross-reactivity, Prevalence, Protein, specificity, Antibody responses, Multiplex assay, Receptor-binding domain, SARS-CoV-2 antibody, response, healthcare, SARS-CoV-2 spike protein, seasonal coronavirus, group, epitope, South Korea, SARS-CoV-2 infections, OC43, HKU1, COVID-19 samples, N-terminal domain, Spike proteins, IgM and IgG, cross-reactive, IgG responses, IgG response, Non-COVID-19, IgM responses, subject, plasma samples, domain, CoVs, human CoVs, South, SARS-CoV-2 nucleocapsid, IgM response, full-length spike protein, serological assessment, human CoV, epitope specificity, responses, plasma sample, robust, human coronavirus, collected, carried, reported, occur, unique, the spike protein, reactivity, antibody response against, COVID-19 sample, diagnosed with COVID-19, the SARS-CoV-2, 【제목키워드】 response, platform, COVID-19 patient, profile,